VISENTIN, ROBERTO
VISENTIN, ROBERTO
Dipartimento di Ingegneria dell'Informazione - DEI
Generating Digital Clones with the UVA/Padova T1D Simulator Identified on CGM and Pump Profiles via a Bayesian Approach
2025 Faggionato, Edoardo; Ekhlaspour, Laya; Buckingham, Bruce A.; Visentin, Roberto
Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An In Silico Study
2024 Visentin, Roberto; Cobelli, Claudio; Sieber, Jochen; Dalla Man, Chiara
Smart Algorithms for Efficient Insulin Therapy Initiation in Individuals With Type 2 Diabetes: An in Silico Study
2024 Bonet, Jacopo; Visentin, Roberto; Dalla Man, Chiara
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations
2024 Visentin, Roberto; Schiavon, Michele; Bonet, Jacopo; Riz, Michela; Wagenhuber, Britta; Man, Chiara Dalla
A PK/PD Simulation Model for Supporting Doxorubicin Therapy in Multiple Myeloma
2023 Andrean, D.; Doshmanziari, R.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery
2023 Visentin, Roberto; Brodersen, Katrine; Richelsen, Bjørn; Møller, Niels; Dalla Man, Chiara; Pedersen, Andreas Kristian; Abrahamsen, Jan; Holst, Jens Juul; Nielsen, Michael Festersen
Model Assessment of Doxorubicin Pharmacokinetics in Multiple Myeloma
2023 Baldan, M.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance
2023 Doshmanziari, Roya; Ros, Francesco Da; Mazzucato, Mario; Pedersen, Morten Gram; Visentin, Roberto
Modeling Doxorubicin Treatment Effect in Multiple Myeloma
2023 Andrean, D.; Da Ros, F.; Mazzucato, M.; Pedersen, M. G.; Visentin, R.
SMART INSULIN THERAPY INITIATION IMPROVES GLUCOSE CONTROL IN INSULIN‐NAÏVE SUBJECTS WITH TYPE 2 DIABETES
2023 Bonet, J.; Visentin, R.; Vettoretti, M.; Facchinetti, A.; Dalla Man, C.
Smart Insulin Therapy Initiation In Insulin-Naive Subjects With Type 2 Diabetes Using Machine Learning
2023 Bonet, Jacopo; Visentin, Roberto; DALLA MAN, Chiara
Smart Titration of Long-Acting Insulin in Insulin-Naïve Type 2 Diabetic Subjects
2023 Bonet, Jacopo; Visentin, Roberto; Vettoretti, Martina; Facchinetti, Andrea; DALLA MAN, Chiara
1426-P: Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve
2022 Visentin, Roberto; Brodersen, Katrine; Richelsen, Bjørn; Moller, Niels; Man, CHIARA DALLA; Nielsen, MICHAEL F.
A software interface for in silico testing of type 2 diabetes treatments
2022 Visentin, R.; Cobelli, C.; Dalla Man, C.
Editorial: Recent Advances in Computer Simulation for Diabetes Treatment and Care
2022 Colmegna, P.; Toffanin, C.; Cescon, M.; Visentin, R.
Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy
2022 Visentin, R.; Cobelli, C.; Sieber, J.; Man, C. D.
IP-IP PADOVA SIMULATOR: INTRAPERITONEAL INSULIN DELIVERY AND GLUCOSE SENSING
2022 Lo Presti, J; Visentin, R; Magni, L; Galderisi, A; Cobelli, C; Toffanin, C
RESIDUAL B-CELL FUNCTION IN SUBJECTS WITH TYPE 2 DIABETES PROTECTS FROM NON-ADHERENCE TO INSULIN THERAPY VERSUS SUBJECTS WITH TYPE 1 DIABETES
2022 Visentin, R; Cobelli, C; Sieber, J; Dalla Man, C
A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes
2021 Visentin, R.; De Lazzari, M.
Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
2021 Lamprinou, A.; Willmann, C.; Machann, J.; Schick, F.; Eckstein, S. S.; Dalla Man, C.; Visentin, R.; Birkenfeld, A. L.; Peter, A.; Stefan, N.; Haring, H. -U.; Fritsche, A.; Heni, M.; Wagner, R.